OPC Pharmaceutical JSC (HOSE:OPC)
22,500
+400 (1.81%)
At close: Mar 5, 2026
OPC Pharmaceutical JSC Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 115,912 | 107,060 | 122,234 | 142,128 | 126,377 | Upgrade
|
| Depreciation & Amortization | 21,555 | 22,218 | 22,895 | 22,819 | 22,502 | Upgrade
|
| Other Amortization | 151.42 | 83.2 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -21,007 | -10,046 | -16,692 | -8,794 | -3,849 | Upgrade
|
| Other Operating Activities | -9,328 | -29,284 | -12,044 | -19,758 | -11,064 | Upgrade
|
| Change in Accounts Receivable | -51,239 | -24,493 | -65,383 | -38,502 | 9,687 | Upgrade
|
| Change in Inventory | -28,655 | -15,257 | 44,070 | 107,395 | 13,615 | Upgrade
|
| Change in Accounts Payable | 40,921 | -24,816 | 1,878 | -11,597 | 33,295 | Upgrade
|
| Change in Other Net Operating Assets | -4,683 | -1,739 | -797.68 | 1,597 | 159.36 | Upgrade
|
| Operating Cash Flow | 63,626 | 23,725 | 255,359 | 36,088 | 190,721 | Upgrade
|
| Operating Cash Flow Growth | 168.18% | -90.71% | 607.60% | -81.08% | 53.61% | Upgrade
|
| Capital Expenditures | -19,873 | -11,578 | -12,042 | -7,399 | -8,912 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 175.97 | - | 182.59 | - | Upgrade
|
| Investment in Securities | 4,070 | -44,230 | 42,529 | -50,830 | 11,966 | Upgrade
|
| Other Investing Activities | 19,899 | 9,146 | 17,655 | 6,905 | 4,983 | Upgrade
|
| Investing Cash Flow | -16,805 | -46,487 | 48,142 | -51,142 | 8,037 | Upgrade
|
| Short-Term Debt Issued | - | - | 36,470 | 17,053 | 309,153 | Upgrade
|
| Total Debt Issued | - | - | 36,470 | 17,053 | 309,153 | Upgrade
|
| Short-Term Debt Repaid | - | - | -36,470 | -88,390 | -314,405 | Upgrade
|
| Total Debt Repaid | - | - | -36,470 | -88,390 | -314,405 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -71,337 | -5,252 | Upgrade
|
| Common Dividends Paid | - | -95,943 | -95,827 | -26,582 | -53,403 | Upgrade
|
| Financing Cash Flow | - | -95,943 | -95,827 | -97,919 | -58,655 | Upgrade
|
| Foreign Exchange Rate Adjustments | 10.13 | 25.3 | 8.98 | 0.03 | 23.66 | Upgrade
|
| Net Cash Flow | 46,832 | -118,680 | 207,683 | -112,973 | 140,127 | Upgrade
|
| Free Cash Flow | 43,753 | 12,147 | 243,317 | 28,688 | 181,809 | Upgrade
|
| Free Cash Flow Growth | 260.20% | -95.01% | 748.14% | -84.22% | 94.78% | Upgrade
|
| Free Cash Flow Margin | 3.90% | 1.25% | 24.21% | 2.45% | 16.18% | Upgrade
|
| Free Cash Flow Per Share | 683.10 | 189.65 | 3798.80 | 447.90 | 2838.51 | Upgrade
|
| Cash Interest Paid | - | - | 334.55 | 1,413 | 4,439 | Upgrade
|
| Cash Income Tax Paid | 30,585 | 28,021 | 35,982 | 37,622 | 37,198 | Upgrade
|
| Levered Free Cash Flow | 55,613 | 12,728 | 94,622 | 149,153 | 204,691 | Upgrade
|
| Unlevered Free Cash Flow | 55,613 | 12,728 | 94,831 | 149,731 | 207,703 | Upgrade
|
| Change in Working Capital | -43,657 | -66,306 | 138,966 | -100,307 | 56,756 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.